TVTX Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Travere Therapeutics Inc

Watchlist Manager

Watchlist

Price: 52.21 USD 0.33% Market Closed

Market Cap: $4.9B

	Travere Therapeutics Inc NASDAQ:TVTX	US
	Boot Barn Holdings Inc NYSE:BOOT	US
T	Thachang Green Energy PCL SET:TGE	TH
	Puig Brands SA F:B1B	ES
A	Autolus Therapeutics PLC SWB:6A3A	UK
J	Jacobs Solutions Inc F:Z0Y	US
C	Contrel Technology Co Ltd TPEX:8064	TW
F	First Citizens BancShares Inc (Delaware) OTC:FCNCB	US
O	Oracle Corp XHAM:ORC	US
	Fincantieri SpA MIL:FCT	IT
A	Avaco Co Ltd KOSDAQ:083930	KR
T	Tokyo Electron Ltd XHAN:TKY	JP

Profitability Summary

Travere Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

96%

Gross Margin is Increasing

94% > 99%

Negative Operating Margin

-7%

Negative 3Y Average Operating Margin

-104%

Operating Margin is Increasing

-231% > -7%

Negative Net Margin

-7%

Negative 3Y Average Net Margin

-69%

Net Margin is Increasing

-56% > -7%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-109%

Free Cash Flow Margin is Increasing

-196% > 3%

Negative ROE

-152%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-99%

ROIC is Increasing

-190% > -16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.